Tyme Technologies, Inc.TYME stock moved upwards by 25.0% to $1.25 during Wednesday's after-market session. The market cap stands at $116.4 million.
Sunesis Pharmaceuticals, Inc.SNSS stock moved upwards by 8.2% to $0.80. The market value of their outstanding shares is at $55.1 million.
ReWalk Robotics, Inc.RWLK stock increased by 7.0% to $3.98. The market value of their outstanding shares is at $22.3 million. The most recent rating by H.C. Wainwright, on June 17, is at Buy, with a price target of $9.00.
MannKind, Inc.MNKD shares rose 6.2% to $1.19. The market cap seems to be at $210.3 million. The most recent rating by BTIG Research, on May 14, is at Buy, with a price target of $3.00.
Nemaura Medical, Inc.NMRD stock rose 5.8% to $1.09. The market value of their outstanding shares is at $183.0 million.
Dermira, Inc.DERM shares rose 5.8% to $8.45. The market value of their outstanding shares is at $415.9 million. The most recent rating by Mizuho, on June 06, is at Buy, with a price target of $14.00.
ViewRay, Inc.VRAY stock surged 5.5% to $6.87. The market cap seems to be at $718.4 million. The most recent rating by Piper Jaffray, on June 18, is at Overweight, with a price target of $15.00.
PetIQ, Inc.PETQ stock increased by 5.4% to $34.00. The market value of their outstanding shares is at $900.7 million. The most recent rating by Guggenheim, on May 23, is at Buy, with a price target of $35.00.
Clearside Biomedical, Inc.CLSD shares surged 5.0% to $1.05. The market value of their outstanding shares is at $39.8 million.
Corbus Pharmaceuticals, Inc.CRBP shares surged 4.9% to $5.98. The market value of their outstanding shares is at $381.2 million.
Fonar, Inc.FONR stock rose 4.5% to $25.00. The market cap stands at $160.9 million.
TherapeuticsMD, Inc.TXMD stock surged 4.4% to $2.36. The market value of their outstanding shares is at $463.1 million.
Regenxbio, Inc.RGNX shares rose 3.6% to $42.01. The market cap stands at $325.5 million. According to the most recent rating by Raymond James, on June 14, the current rating is at Outperform.
Aevi Genomic Medicine, Inc.GNMX stock moved upwards by 3.4% to $0.24. The market cap stands at $10.3 million.
Lexicon Pharmaceuticals, Inc.LXRX shares rose 3.0% to $1.36. The market cap stands at $1.1 billion. The most recent rating by Citigroup, on July 30, is at Buy, with a price target of $3.00.
Athersys, Inc.ATHX shares moved upwards by 3.0% to $1.39. The market cap stands at $197.7 million.
Aclaris Therapeutics, Inc.ACRS shares rose 2.9% to $1.05. The market value of their outstanding shares is at $530.7 million. According to the most recent rating by SVB Leerink, on June 27, the current rating is at Market Perform.
Vical, Inc.VICL stock rose 2.9% to $0.83. The market value of their outstanding shares is at $16.2 million.
Aurora Cannabis, Inc.ACB shares rose 2.4% to $6.78. The market value of their outstanding shares is at $6.4 billion. According to the most recent rating by Bank of America, on July 18, the current rating is at Neutral.
Paratek Pharmaceuticals, Inc.PRTK shares rose 2.4% to $4.27. The market value of their outstanding shares is at $100.4 million.
Titan Medical, Inc.TMDI shares surged 2.2% to $2.30. The most recent rating by Piper Jaffray, on May 22, is at Overweight, with a price target of $6.00.
G1 Therapeutics, Inc.GTHX shares surged 2.2% to $24.00. The market cap stands at $690.5 million.
Tetraphase Pharmaceutical, Inc.TTPH shares increased by 2.1% to $0.34. The market cap seems to be at $187.1 million.
Valeritas Holdings, Inc.VLRX stock rose 2.1% to $2.96. The market cap seems to be at $15.0 million.
OPKO Health, Inc.OPK shares surged 2.0% to $1.99. The market cap seems to be at $2.1 billion.
Losers
ICU Medical, Inc.ICUI stock declined 29.1% to $174.25 during Wednesday's after-market session. The market value of their outstanding shares is at $5.1 billion.
Dynavax Technologies, Inc.DVAX shares plummeted 16.1% to $2.51. The market value of their outstanding shares is at $187.3 million. According to the most recent rating by Cantor Fitzgerald, on July 11, the current rating is at Overweight.
Miragen Therapeutics, Inc.MGEN stock plummeted 15.3% to $1.33. The market cap stands at $213.4 million.
Neovasc, Inc.NVCN shares plummeted 10.9% to $2.85. The market cap stands at $20.9 million.
Clovis Oncology, Inc.CLVS stock decreased by 9.8% to $8.09. According to the most recent rating by Guggenheim, on August 02, the current rating is at Neutral.
Zynerba Pharmaceuticals, Inc.ZYNE stock fell 8.7% to $10.65. The market cap seems to be at $92.7 million.
MeiraGTx Holdings, Inc.MGTX shares declined 8.1% to $23.50. The market cap stands at $828.5 million.
Ocular Therapeutix, Inc.OCUL stock decreased by 6.8% to $4.26. The market cap seems to be at $200.4 million. According to the most recent rating by Cowen & Co., on May 21, the current rating is at Market Perform.
Glaukos, Inc.GKOS stock decreased by 6.0% to $68.68. The market cap seems to be at $2.7 billion.
Sarepta Therapeutics, Inc.SRPT shares declined 4.8% to $135.50. The market value of their outstanding shares is at $6.1 billion. The most recent rating by Morgan Stanley, on July 09, is at Overweight, with a price target of $220.00.
Stemline Therapeutics, Inc.STML shares declined 4.0% to $16.90. The market cap stands at $156.3 million. According to the most recent rating by Wedbush, on May 13, the current rating is at Neutral.
Five Star Senior Living, Inc.FVE stock decreased by 3.5% to $0.53. The market cap stands at $23.4 million.
Durect, Inc.DRRX shares fell 3.0% to $1.30. The market cap seems to be at $105.8 million.
Immunomedics, Inc.IMMU shares decreased by 2.8% to $14.38. The market value of their outstanding shares is at $2.6 billion.
Arena Pharmaceuticals, Inc.ARNA stock declined 2.6% to $59.30. The market value of their outstanding shares is at $2.9 billion.
Foamix Pharmaceuticals, Inc.FOMX shares decreased by 2.5% to $2.30. The market cap stands at $130.1 million. The most recent rating by Barclays, on June 11, is at Overweight, with a price target of $10.00.
Catalyst Pharmaceuticals, Inc.CPRX shares decreased by 2.5% to $5.00. The market value of their outstanding shares is at $513.2 million.
